Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yves Beguin

Showing results (151-160 of 243) with videos related to

Pageof 25
Sort By:
Frontiers in Immunology|April 20, 2019
Comparison of Mesenchymal Stromal Cells From Different Origins for the Treatment of Graft-vs.-Host-Disease in a Humanized Mouse ModelCéline Grégoire, Caroline Ritacco, Muriel Hannon, et al.
Stem Cell Research & Therapy|December 3, 2024
Co-infusion of mesenchymal stromal cells to prevent GVHD after allogeneic hematopoietic cell transplantation from HLA-mismatched unrelated donors after reduced-intensity conditioning: a double-blind randomized study and literature reviewGérôme Lombardo, Chantal Lechanteur, Alexandra Briquet, et al.
Journal of Neurophysiology|May 27, 2025
EEG characteristics of central nervous system graft-versus-host diseaseNicolas Lambert, Majdouline El Moussaoui, Jan Brijs, et al.
Journal of Hematology & Oncology|July 6, 2016
Azacytidine mitigates experimental sclerodermic chronic graft-versus-host diseaseGilles Fransolet, Grégory Ehx, Joan Somja, et al.
Talanta|May 21, 2014
Comprehensive plasma profiling for the characterization of graft-versus-host disease biomarkersMuriel De Bock, Yves Beguin, Pierre Leprince, et al.
Bulletin Du Cancer|November 16, 2016
[Assessment and management of post-transplant iron overload: Guidelines of the Francophone Society of Marrow Transplantation and Cellular Therapy (SFGM-TC)]Aurélie Jaspers, Salaheddine Bouhya, Stéphanie Belaiche, et al.
Bone Marrow Transplantation|October 6, 2021
Sequential administration of low dose 5-azacytidine (AZA) and donor lymphocyte infusion (DLI) for patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) in relapse after allogeneic stem cell transplantation (SCT): a prospective study from the Belgian Hematology Society (BHS)Xavier Poiré, Carlos Graux, Aurélie Ory, et al.
Journal of Hematology & Oncology|May 21, 2020
Allogeneic stem cell transplantation for peripheral T cell lymphomas: a retrospective study in 285 patients from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)Anne-Claire Mamez, Axelle Dupont, Didier Blaise, et al.
Cancers|March 1, 2019
Loss of Stromal Galectin-1 Enhances Multiple Myeloma Development: Emphasis on a Role in OsteoclastsJoséphine Muller, Elodie Duray, Margaux Lejeune, et al.
Bone Marrow Transplantation|January 9, 2023
Nilotinib efficacy and safety as salvage treatment following imatinib intolerance and/or inefficacy in steroid refractory chronic graft-versus-host-disease (SR-cGVHD): a prospective, multicenter, phase II study on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)Micha Srour, Tamim Alsuliman, Julien Labreuche, et al.
Pageof 25

Showing results (151-160 of 243) with videos related to

Sort By:
Pageof 25
Frontiers in Immunology|April 20, 2019
Comparison of Mesenchymal Stromal Cells From Different Origins for the Treatment of Graft-vs.-Host-Disease in a Humanized Mouse ModelCéline Grégoire, Caroline Ritacco, Muriel Hannon, et al.
Stem Cell Research & Therapy|December 3, 2024
Co-infusion of mesenchymal stromal cells to prevent GVHD after allogeneic hematopoietic cell transplantation from HLA-mismatched unrelated donors after reduced-intensity conditioning: a double-blind randomized study and literature reviewGérôme Lombardo, Chantal Lechanteur, Alexandra Briquet, et al.
Journal of Neurophysiology|May 27, 2025
EEG characteristics of central nervous system graft-versus-host diseaseNicolas Lambert, Majdouline El Moussaoui, Jan Brijs, et al.
Journal of Hematology & Oncology|July 6, 2016
Azacytidine mitigates experimental sclerodermic chronic graft-versus-host diseaseGilles Fransolet, Grégory Ehx, Joan Somja, et al.
Talanta|May 21, 2014
Comprehensive plasma profiling for the characterization of graft-versus-host disease biomarkersMuriel De Bock, Yves Beguin, Pierre Leprince, et al.
Bulletin Du Cancer|November 16, 2016
[Assessment and management of post-transplant iron overload: Guidelines of the Francophone Society of Marrow Transplantation and Cellular Therapy (SFGM-TC)]Aurélie Jaspers, Salaheddine Bouhya, Stéphanie Belaiche, et al.
Bone Marrow Transplantation|October 6, 2021
Sequential administration of low dose 5-azacytidine (AZA) and donor lymphocyte infusion (DLI) for patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) in relapse after allogeneic stem cell transplantation (SCT): a prospective study from the Belgian Hematology Society (BHS)Xavier Poiré, Carlos Graux, Aurélie Ory, et al.
Journal of Hematology & Oncology|May 21, 2020
Allogeneic stem cell transplantation for peripheral T cell lymphomas: a retrospective study in 285 patients from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)Anne-Claire Mamez, Axelle Dupont, Didier Blaise, et al.
Cancers|March 1, 2019
Loss of Stromal Galectin-1 Enhances Multiple Myeloma Development: Emphasis on a Role in OsteoclastsJoséphine Muller, Elodie Duray, Margaux Lejeune, et al.
Bone Marrow Transplantation|January 9, 2023
Nilotinib efficacy and safety as salvage treatment following imatinib intolerance and/or inefficacy in steroid refractory chronic graft-versus-host-disease (SR-cGVHD): a prospective, multicenter, phase II study on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)Micha Srour, Tamim Alsuliman, Julien Labreuche, et al.
Pageof 25